Fiche centre
Nanfang Hospital, Southern Medical University
Guangzhou — China
Essais liés6clinical trials
VilleGuangzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05979441
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ipatasertib | Cancer | Phase 3 | NCT05862285 | UmbrellaMAX — A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study | RECRUITING |
| Finerenone | Insuffisance cardiaque | Phase 3 | NCT07575672 | FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure | RECRUITING |
| Efgartigimod PH20 SC | Myopathies | Phase 3 | NCT05979441 | ALKIVIA+ — A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy | ENROLLING_BY_INVITATION |
| Tacabrutideg | Cancer | Phase 1/2 | NCT05006716 | CaDAnCe-101 — A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies | RECRUITING |
| B007 | Myasthénie | Phase 2/3 | NCT06447597 | A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. | RECRUITING |
| mNGS for IFD in Patients With Hematological Malignancies | Cancer | À vérifier | NCT07763184 | mNGS for IFD in Patients With Hematological Malignancies | NOT_YET_RECRUITING |